Detalles de la búsqueda
1.
Fostering cultural sensitivity amongst students of pharmacy through an interprofessional book club activity.
Curr Pharm Teach Learn
; 14(3): 379-386, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35307100
2.
Optimization of a dihydropyrrolopyrazole series of transforming growth factor-beta type I receptor kinase domain inhibitors: discovery of an orally bioavailable transforming growth factor-beta receptor type I inhibitor as antitumor agent.
J Med Chem
; 51(7): 2302-6, 2008 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-18314943
3.
Preclinical assessment of galunisertib (LY2157299 monohydrate), a first-in-class transforming growth factor-ß receptor type I inhibitor.
Oncotarget
; 9(6): 6659-6677, 2018 Jan 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-29467918
4.
Dihydropyrrolopyrazole transforming growth factor-beta type I receptor kinase domain inhibitors: a novel benzimidazole series with selectivity versus transforming growth factor-beta type II receptor kinase and mixed lineage kinase-7.
J Med Chem
; 49(6): 2138-42, 2006 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-16539403
5.
Comprehensive perinatal safety initiative to reduce adverse obstetric events.
J Healthc Qual
; 34(1): 6-15, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22060764
6.
Synthesis and activity of new aryl- and heteroaryl-substituted 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole inhibitors of the transforming growth factor-beta type I receptor kinase domain.
Bioorg Med Chem Lett
; 14(13): 3581-4, 2004 Jul 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-15177479
Resultados
1 -
6
de 6
1
Próxima >
>>